SUMMARY:
MRI findings will be helpful for genotype-phenotype correlation and will widen understanding about the clinical spectrum of CMT1C.
TITLE:
Identification and clinical characterization of Charcot-Marie-Tooth disease type 1C patients with LITAF p.G112S mutation
DESCRIPTION:
CONCLUSIONS: We found a conduction block in Korean CMT1C patients with p.G112S mutation and first described the characteristic MRI findings of the lower extremities in patients with LITAF mutation. These findings will be helpful for genotype-phenotype correlation and will widen understanding about the clinical spectrum of CMT1C.
CONTENT:
Genes Genomics. 2022 May 24. doi: 10.1007/s13258-022-01253-w. Online ahead of print.
ABSTRACT
BACKGROUND: Charcot-Marie-Tooth disease type 1C (CMT1C) is a rare subtype associated with LITAF gene mutations. Until now, only a few studies have reported the clinical features of CMT1C.
OBJECTIVE: This study was performed to find CMT1C patients with mutation of LITAF in a Korean CMT cohort and to characterize their clinical features.
METHODS: In total, 1,143 unrelated Korean families with CMT were enrolled in a cohort. We performed whole exome sequencing to identify LITAF mutations, and examined clinical phenotypes including electrophysiological and MRI features for the identified CMT1C patients.
RESULTS: We identified 10 CMT1C patients from three unrelated families with p.G112S mutation in LITAF. The frequency of CMT1C among CMT1 patients was 0.59%, which is similar to reports from Western populations. CMT1C patients showed milder symptoms than CMT1A patients. The mean CMT neuropathy score version 2 was 7.7, and the mean functional disability scale was 1.0. Electrophysiological findings showed a conduction block in 22% of affected individuals. Lower extremity MRIs showed that the superficial posterior and anterolateral compartments of the calf were predominantly affected.
CONCLUSIONS: We found a conduction block in Korean CMT1C patients with p.G112S mutation and first described the characteristic MRI findings of the lower extremities in patients with LITAF mutation. These findings will be helpful for genotype-phenotype correlation and will widen understanding about the clinical spectrum of CMT1C.
PMID:35608774 | DOI:10.1007/s13258-022-01253-w
SOURCE:
Genes & genomics
TAGS:
MRI
CATEGORY:
Research
SUBCATEGORY:
n/a
DATE – PUBLISHED:
2022-05-24T09:22:10Z
DATE – DOI: 2022-05-24T09:22:10Z
DATE – PUBMED: 2022 May 24
DATE OUTPUT MATCHED: True
DATE – ADDED:
Tue, 24 May 2022 06:00:00 -0400
DATE – RETRIEVED:
05/24/22 01:05PM
2022-05-24T13:05:05-04:00
FEATURED IMAGE:
Media Uploaded (image/png)
IDENTIFIER:
pmid:35608774,doi:10.1007/s13258-022-01253-w
PUBMED ID:
pubmed:35608774
DOI:
10.1007/s13258-022-01253-w
LINK – PUBMED:
https://pubmed.ncbi.nlm.nih.gov/35608774/
LINK – DOI:
https://doi.org/10.1007/s13258-022-01253-w
LINK – PUBLISHER:
https://link.springer.com/10.1007/s13258-022-01253-w
REFERENCES:
CMT Treatment Report, Urgent Research, 2022-05-24T13:05:05-04:00, https://www.cmttreatmentreport.com.
